Simplex Trading’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,700
Closed -$23K 10766
2022
Q4
$23K Hold
7,700
﹤0.01% 6756
2022
Q3
$23K Buy
+7,700
New +$18.9K ﹤0.01% 7398
2022
Q2
Sell
-4,800
Closed -$18K 11765
2022
Q1
$18K Buy
+4,800
New +$19.9K ﹤0.01% 8387
2021
Q4
Sell
-900
Closed -$4K 12038
2021
Q3
$4K Hold
900
﹤0.01% 9389
2021
Q2
$4K Buy
+900
New +$4.71K ﹤0.01% 9574
2021
Q1
Sell
-12
Closed -$4K 10635
2020
Q4
$4K Buy
12
+2
+20% +$8 ﹤0.01% 7843
2020
Q3
$3K Buy
+10
New +$35 ﹤0.01% 7371
2019
Q1
Sell
-3
Closed -$1K 8412
2018
Q4
$1K Sell
3
-51
-94% -$326 ﹤0.01% 6871
2018
Q3
$37K Buy
+54
New +$406 ﹤0.01% 5464
2018
Q2
Sell
-119
Closed -$6K 8337
2018
Q1
$6K Buy
+119
New +$1.22K ﹤0.01% 4570

Other funds holding CO

Simplex Trading's CO Position: Q1 2023 in Review

Simplex Trading sold out of Global Cord Blood Corporation (CO) in Q1 2023, closing a stake of 7,338 shares — an estimated $21K sold.

Simplex Trading first reported a position in CO in Q3 2017 and held it in 21 quarters. The position peaked at $124K in Q1 2022. 23 funds tracked by Wall St. Rank hold CO as of Q1 2023.

  • Simplex Trading reported no remaining Global Cord Blood Corporation position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 7,338 Global Cord Blood Corporation shares in Q1 2023, an estimated $21K.
  • Simplex Trading first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 21 quarters.
  • Simplex Trading's Global Cord Blood Corporation position peaked at $124K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.